中国医药(600056.SH)：前三季度净利润4.55亿元，同比下降4.64%

Core Viewpoint - China Medical (600056.SH) reported a decline in revenue and net profit for the first three quarters of 2025 compared to the previous year [1] Financial Performance - The total operating revenue for the first three quarters reached 25.894 billion yuan, representing a year-on-year decrease of 3.42% [1] - The net profit attributable to shareholders was 455 million yuan, down 4.64% year-on-year [1] - The basic earnings per share stood at 0.304 yuan [1]